Chapter 26. Non-Alcoholic Fatty Liver Disease

  1. John WD McDonald1,
  2. Andrew K Burroughs2 and
  3. Brian G Feagan3
  1. Chris P Day

Published Online: 25 OCT 2007

DOI: 10.1002/9780470987025.ch26

Evidence-based Gastroenterology and Hepatology, Second Edition

Evidence-based Gastroenterology and Hepatology, Second Edition

How to Cite

Day, C. P. (2004) Non-Alcoholic Fatty Liver Disease, in Evidence-based Gastroenterology and Hepatology, Second Edition (eds J. W. McDonald, A. K. Burroughs and B. G. Feagan), Blackwell Publishing Ltd, Oxford, UK. doi: 10.1002/9780470987025.ch26

Editor Information

  1. 1

    Professor of Medicine, University of Western Ontario, Gastroenterology Service, London Health Sciences Centre, London, Ontario, Canada

  2. 2

    Consultant Physician/Hepatologist, Royal Free Hospital, London, UK

  3. 3

    Professor of Medicine, University of Western Ontario, Gastroenterology Service, London Health Sciences Centre, London, Ontario, Canada

Publication History

  1. Published Online: 25 OCT 2007
  2. Published Print: 10 NOV 2004

ISBN Information

Print ISBN: 9780727917515

Online ISBN: 9780470987025

SEARCH

Keywords:

  • non-alcoholic fatty liver disease;
  • metabolic syndrome;
  • hypertriglyceridemia;
  • hypertension;
  • diabetes mellitus

Summary

This chapter contains sections titled:

  • Introduction

  • Natural history of non-alcoholic fatty liver disease

  • Investigation of patients with suspected non-alcoholic fatty liver disease

  • Risk factors for advanced non-alcoholic fatty liver disease

  • General management strategies

  • Management of the metabolic syndrome

  • Treatment directed at achieving weight reduction

  • Treatment directed at associated diabetes mellitus/insulin resistance

  • Treatment directed at associated lipid abnormalities

  • Antihypertensive therapy

  • Liver-specific therapies

  • Liver transplantation for patients with non-alcoholic fatty liver disease

  • Conclusions